
641569-94-0 Nilotinib Intermediate
Product name:Benzoic acid,4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acidCAS:641569-94-0. MF:C17H14N4O2. MW:306.32. EINECS:629-968-8. MDL No.:MFCD11521324
Add to Inquiry
CAS 1632-16-2 | 2-Ethyl-1-hexene
Name: 2-ETHYL-1-HEXENECAS number: 1632-16-2Molecular formula: C8H16Molecular weight: 112.21EINECS number: 216-636-9MDL No.:MFCD00027242
Add to Inquiry
CAS 1416134-48-9 | Avibactam INT 1
Name: Avibactam INT 1CAS number: 1416134-48-9Molecular formula: C17H24N2O7Molecular weight: 368.38EINECS number:MDL No.:MFCD29918783
Add to Inquiry
CAS 3027931-27-4 | PBA-Q76-O16B
CAS No.3027931-27-4Molecular Weight: 914.27Formula:C47H86BN2O6S4+
Add to Inquiry
CAS 22009-37-6| 7-Methyl-1-Tetralone
Name: 7-Methyl-1-TetraloneCAS number: 22009-37-6Molecular formula: C11H12OMolecular weight: 160.21EINECS number: 244-717-9MDL No.:MFCD00087600
Add to Inquiry
68077-26-9 NORFLOXACIN Q-ACID
CAS:68077-26-9MF:C12H9ClFNO3MW:269.66EINECS:614-262-4MDL No.:MFCD00792459
Add to Inquiry
25383-06-6 Fosfomycin Intermediate
CAS:25383-06-6. MF:C3H7O3P. MW:122.06. EINECS:246-928-1. MDL No.:MFCD22373409
Add to Inquiry
54527-65-0 2-(benzylmethylamino)ethyl Acetoacetate
CAS:54527-65-0. MF:C14H19NO3. MW:249.31. EINECS:259-197-9. MDL No.:MFCD00071539
Add to Inquiry
134790-39-9
CAS:134790-39-9. MF:C23H19F2N3O6. MW:471.41. EINECS:603-873-1. MDL No.:MFCD09837611
Add to Inquiry
151533-22-1 L-5-methyltetrahydrofolate Calcium
Product name:L-5-methyltetrahydrofolate CalciumCAS:151533-22-1. MF:C20H27CaN7O6. MW:501.56. EINECS:691-636-3. MDL No.:MFCD18642975
Add to Inquiry
6628-04-2 4-amino-2-methylquinoline
CAS:6628-04-2. MF:C10H10N2. MW:158.2. EINECS:229-604-4. MDL No.:MFCD00006759
Add to Inquiry
67914-60-7
Product name:1-Acetyl-4-(4-hydroxyphenyl)piperazineCAS:67914-60-7. MF:C12H16N2O2. MW:220.27. EINECS:267-744-8. MDL No.:MFCD00044905
Add to Inquiry
China Nilotinib intermediate Manufacturers Factory Suppliers
Relying on mass production and reliable quality, our alternative intermediate, cost effective intermediate, mainstream product intermediate is well-received in domestic and international markets and has gained a good reputation from our customers.We always adhere to the business philosophy of building a brand with quality, creating a future with integrity, based on quality, service as the core, and win-win as the goal, invest in the industry with unlimited enthusiasm, and focus on Nilotinib intermediatefor many years. Our team is made up of experienced professionals, with a shared commitment to excellence, innovation, and customer satisfaction. We insist on the basic guideline of customer-centeredness and take it as a long-term strategy. Our team is dedicated to delivering the highest standards of quality and value. Our products are designed to be versatile and adaptable to different industries and applications. We are committed to providing our employees with a safe and healthy work environment. We have a comprehensive distribution network to ensure wide reach.WEBNilotinib, an oral inhibitor of the tyrosine kinase activity of Abelson protein, is approved for the treatment of patients with newly diagnosed chronic myeloid leukemia (CML) in...
WEBJan 7, 2021 · In patients on treatment for >5 years, CVEs occurred more frequently among patients in the high-risk (nilotinib 300-mg twice-daily, 33.3%; nilotinib 400-mg twice...
WEBPublished: 07 January 2021. Chronic myelogenous leukemia. Long-term outcomes with frontline nilotinib versus imatinib in newly diagnosed chronic myeloid leukemia in...
WEBNilotinib is a transduction inhibitor that targets BCR-ABL, c-kit and PDGF, for the potential treatment of various leukemias, including chronic myeloid leukemia (CML). Mechanism...
WEBSep 4, 2018 · Nilotinib, an oral inhibitor of the tyrosine kinase activity of Abelson protein, is approved for the treatment of patients with newly...
WEBJun 17, 2010 · Nilotinib has been shown to be a more potent inhibitor of BCR-ABL than imatinib. We evaluated the efficacy and safety of...
